Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes
Primary Purpose
Type 2 Diabetes
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
herbal extract; root of woody shrub grown in India/Sri-Lanka
Sponsored by

About this trial
This is an interventional treatment trial for Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria:
- type 2 diabetes
- Between 18 and 75 years of age
- Male or non-pregnant, non-lactating female, at least 6 weeks postpartum
- If of childbearing potential, is practicing birth control
- BMI is more than or equal to 18kg/m2 and less than or equal to 35kg/m2
- If on anti-hyperglycemic, anti-hypertensive, lipid-lowering, or thyroid medications or hormone therapy, has been on constant dosage for at least 3 months prior to screening visit
Exclusion Criteria:
- Uses insulin for glucose control or has type 1 diabetes
- History of diabetic ketoacidosis.
- Current infection; surgery or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks.
- Active malignancy
- Significant cardiovascular event less than or equal to 6 months prior to screening visit or history of congestive heart failure
- End state organ failure or status post organ transplant
- History of renal disease
- Current hepatic disease
- History of severe gastroparesis
- Has a chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV
- Currently taking herbals, dietary supplements, or medications, other than anti-hyperglycemic medications, during the past 4 weeks that could profoundly affect blood glucose
- Clotting or bleeding disorders
- Allergic or intolerant to any ingredient found in the study products
Sites / Locations
- Radiant Research
- Radiant Research
Outcomes
Primary Outcome Measures
positive AUC for plasma glucose
Secondary Outcome Measures
positive AUC for serum insulin; adjusted peak values for plasma glucose and serum insulin; baseline plasma glucose and serum insulin concentrations; adjusted values for plasma glucose and serum insulin at individual postprandial time points.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00499148
Brief Title
Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes
Official Title
Effect of Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes
Study Type
Interventional
2. Study Status
Record Verification Date
April 2009
Overall Recruitment Status
Completed
Study Start Date
August 2006 (undefined)
Primary Completion Date
August 2007 (Actual)
Study Completion Date
October 2007 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Abbott Nutrition
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the study was to evaluate the effect of an herbal extract on postprandial glycemia following a meal.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Crossover Assignment
Masking
Double
Allocation
Randomized
Enrollment
59 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Other
Intervention Name(s)
herbal extract; root of woody shrub grown in India/Sri-Lanka
Primary Outcome Measure Information:
Title
positive AUC for plasma glucose
Time Frame
4 hours
Secondary Outcome Measure Information:
Title
positive AUC for serum insulin; adjusted peak values for plasma glucose and serum insulin; baseline plasma glucose and serum insulin concentrations; adjusted values for plasma glucose and serum insulin at individual postprandial time points.
Time Frame
4 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
type 2 diabetes
Between 18 and 75 years of age
Male or non-pregnant, non-lactating female, at least 6 weeks postpartum
If of childbearing potential, is practicing birth control
BMI is more than or equal to 18kg/m2 and less than or equal to 35kg/m2
If on anti-hyperglycemic, anti-hypertensive, lipid-lowering, or thyroid medications or hormone therapy, has been on constant dosage for at least 3 months prior to screening visit
Exclusion Criteria:
Uses insulin for glucose control or has type 1 diabetes
History of diabetic ketoacidosis.
Current infection; surgery or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks.
Active malignancy
Significant cardiovascular event less than or equal to 6 months prior to screening visit or history of congestive heart failure
End state organ failure or status post organ transplant
History of renal disease
Current hepatic disease
History of severe gastroparesis
Has a chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV
Currently taking herbals, dietary supplements, or medications, other than anti-hyperglycemic medications, during the past 4 weeks that could profoundly affect blood glucose
Clotting or bleeding disorders
Allergic or intolerant to any ingredient found in the study products
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer A. Williams, MPH
Organizational Affiliation
Abbott Nutrition
Official's Role
Study Director
Facility Information:
Facility Name
Radiant Research
City
Edina
State/Province
Minnesota
ZIP/Postal Code
55435
Country
United States
Facility Name
Radiant Research
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45249
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes
We'll reach out to this number within 24 hrs